| ALK | Anaplastic lymphoma kinase |
| AML | Acute myeloid leukemia |
| BTK | Bruton’s tyrosine kinase |
| Car-DPPYs | carbonyl-substituted diphenylpyrimidine derivatives |
| DFG | (Asp-Phe-Gly) motif |
| DPPYs | Diphenylpyrimidine analogs |
| EGFR | Endothelial growth factor receptor |
| ERK | Extracellular signal-regulated kinases |
| FAK | Focal adhesion kinase |
| FAKIs | FAK inhibitors |
| FAT | Focal Adhesion Targeting |
| GBM | Malignant glioblastoma |
| Grb2 | Growth factor receptor-bound protein 2 |
| HCC | Hepatocellular carcinoma cell |
| HDAC | histone deacetylases |
| HUVEC | Human Umbilical Vein Endothelial Cells |
| IGF-IR | Insulin-like growth factor-I receptor |
| JNK | Janus kinase |
| MAPK | Mitogen-activated protein kinase kinase |
| NSCLC | Non-small cell lung cancer |
| NF-kB | Nuclear factor-κB |
| PA-DPPYs | phosphamide-containing diphenylpyrimidine analogs |
| PC | pancreatic cells |
| PDGFR | Platelet-derived growth factor receptor |
| PET | Positron emission tomography |
| PROTAC | Proteolysis targeting chimera |
| PRP | Poly-prolin- rich sequences |
| Pyk2 | Proline-rich tyrosine kinase 2 |
| ROS | reactive oxygen species |
| Sul-DPPYs | sulphonamide-substituted diphenylpyrimidine derivatives |
| TOP1 | Topoisomerase I |
| VEGFR | Vascular endothelial growth factor receptor |
| VHL | Von Hippel-Lindau |